Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (5) , 300.e1-300.e7
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (UL1TR001422)
- American Association of Medical Colleges
- VA Merit Award (BX003692-01)
This publication has 16 references indexed in Scilit:
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and OutcomesEuropean Urology, 2016
- Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancerBJU International, 2015
- Enabling a Learning Health System through a Unified Enterprise Data Warehouse: The Experience of the Northwestern University Clinical and Translational Sciences (NUCATS) InstituteClinical and Translational Science, 2015
- Gender, Race, and Variation in the Evaluation of Microscopic Hematuria Among Medicare BeneficiariesJournal of General Internal Medicine, 2014
- Gender Disparities in Hematuria Evaluation and Bladder Cancer Diagnosis: A Population Based AnalysisJournal of Urology, 2014
- Variation in the Intensity of Hematuria Evaluation: A Target for Primary Care Quality ImprovementThe American Journal of Medicine, 2014
- Cancer survival disparities by health insurance statusCancer Medicine, 2013
- Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA GuidelineJournal of Urology, 2012
- Delays in diagnosis and bladder cancer mortalityCancer, 2010
- Patterns of Hematuria Referral to Urologists: Does a Gender Disparity Exist?Urology, 2008